Quarterly Report (10-q)

Date : 01/10/2019 @ 3:10PM
Source : Edgar (US Regulatory)
Stock : Jubilant Flame International Ltd. (QB) (JFIL)
Quote : 0.03  0.0 (0.00%) @ 1:00AM

Quarterly Report (10-q)

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 

FORM 10-Q

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended November 30, 2018

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number 333 -173456

 

Jubilant Flame International, LTD

(Exact name of registrant as specified in its charter)

  

Nevada

(State or other jurisdiction of incorporation or organization)

 

10F., YUNFENG BUILDING, NO. 478 WUZHONG RD, Shanghai, China 201103

(Address of principal executive offices, including zip code.)

 

+ 86 21 64748888

(Registrant's telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES  x NO ¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files) YES  x NO ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a small reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “small reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

¨

Accelerated filer

¨

Non-accelerated filer

¨

Smaller reporting company

x

Emerging growth company

¨

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes  ¨ No x

 

As of January 10, 2019, there are 18,485,708 shares of common stock outstanding.

   

All references in this Report on Form 10-Q to the terms “we”, “our”, “us”, the “Company” and the “Registrant” refer to Jubilant Flame International Ltd unless the context indicates another meaning.

 

 
 
 
 

 

JUBILANT FLAME INTERNATIONAL LTD

 

TABLE OF CONTENTS

 

 

 

 

Page

 

 

 

 

 

 

PART I – FINANCIAL INFORMATION

 

 

Item 1.

Financial Statements

 

 

F-1

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

3

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

6

 

Item 4.

Controls and Procedures

 

 

6

 

 

 

 

 

PART II – OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

 

 

7

 

Item 1A.

Risk Factors

 

 

7

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

 

7

 

Item 3.

Defaults Upon Senior Securities

 

 

7

 

Item 4.

Mine Safety Disclosures

 

 

7

 

Item 5.

Other Information

 

 

7

 

Item 6.

Exhibits

 

 

8

 

SIGNATURES

 

 

9

 

  

 
2
 
 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

JUBILANT FLAME INTERNATIONAL, LTD.

FOR THE THREE AND NINE MONTH PERIODS ENDED NOVEMBER 30, 2018 AND 2017

 

Index to Unaudited Financial Statements

 

Contents

 

 

Page

 

Balance Sheets November 30, 2018 and February 28, 2018 (Unaudited)

 

 

F-2

 

Statements of Operations for the Three and nine-Month Periods Ended November 30, 2018 and 2017 (Unaudited)

 

 

F-3

 

Statements of Changes in Stockholders’ Deficit for the Nine Months Ended November 30, 2018 (Unaudited)

 

 

F-4

 

Statements of Cash Flows for the Nine-Month Periods Ended November 30, 2018 and 2017 (Unaudited)

 

 

F-5

 

Notes to the Financial Statements (Unaudited)

 

 

F-6

 

 

 
F-1
 
Table of Contents

 

JUBILANT FLAME INTERNATIONAL, LTD

Balance Sheets

(Unaudited)

 

 

 

November 30,

 

 

February 28,

 

 

 

2018

 

 

2018

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

Cash

 

$ 15,881

 

 

$ 8,036

 

Account receivable

 

 

2,964

 

 

 

594

 

Inventory

 

 

9,813

 

 

 

5,933

 

Prepaid expenses

 

 

12,000

 

 

 

7,500

 

Total current assets

 

 

40,658

 

 

 

22,063

 

 

 

 

 

 

 

 

 

 

Other assets

 

 

 

 

 

 

 

 

Website net of $25,000 and $21,527 of amortization, respectively

 

 

-

 

 

 

3,473

 

Total other assets

 

 

-

 

 

 

3,473

 

 

 

 

 

 

 

 

 

 

Total Assets

 

$ 40,658

 

 

$ 25,536

 

 

 

 

 

 

 

 

 

 

LIABILITIES & STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$ 3,169

 

 

$ -

 

Due to related party

 

 

41,835

 

 

 

12,842

 

Accrued officer compensation

 

 

535,500

 

 

 

460,125

 

Loan payable - related parties

 

 

438,149

 

 

 

390,828

 

Total current liabilities

 

 

1,018,653

 

 

 

863,795

 

 

 

 

 

 

 

 

 

 

Total Liabilities

 

 

1,018,653

 

 

 

863,795

 

 

 

 

 

 

 

 

 

 

Stockholders' Deficit

 

 

 

 

 

 

 

 

Common stock, $0.001 par value per share

 

 

 

 

 

 

 

 

75,000,000 shares authorized; 18,485,708 and

 

 

 

 

 

 

 

 

18,410,708 shares issued and outstanding, respectively

 

 

18,486

 

 

 

18,411

 

Additional paid in capital

 

 

2,416,545

 

 

 

2,259,120

 

Accumulated deficit

 

 

(3,413,026 )

 

 

(3,115,790 )

Total Stockholders' Deficit

 

 

(977,995 )

 

 

(838,259 )

 

 

 

 

 

 

 

 

 

Total Liabilities and Stockholders' Deficit

 

$ 40,658

 

 

$ 25,536

 

 

The accompanying notes are an integral part of these financial statements.

 

 
F-2
 
Table of Contents

 

JUBILANT FLAME INTERNATIONAL, LTD

Statements of Operations

(Unaudited)

 

 

 

For the three months ended

 

 

For the nine months ended

 

 

 

November 30,

 

 

November 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales of goods

 

$ 24,099

 

 

$ -

 

 

$ 38,190

 

 

 

-

 

Total sales

 

 

24,099

 

 

 

-

 

 

 

38,190

 

 

 

-

 

Costs and Operating Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

 

16,856

 

 

 

-

 

 

 

24,342

 

 

 

-

 

Operating, selling, general and administrative

 

 

101,458

 

 

 

171,429

 

 

$ 311,084

 

 

$ 526,351

 

Total operating expenses

 

 

118,314

 

 

 

171,429

 

 

 

335,426

 

 

 

526,351

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

 

(94,215 )

 

 

(171,429 )

 

 

(297,236 )

 

 

(526,351 )

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change and gain in derivatives liability

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3,120 )

Debt discount amortization expense

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,238 )

Interest expense

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(320 )

Other income (expense) net

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(7,678 )

Income (loss) from continuing operations before provision for income taxes

 

 

(94,215 )

 

 

(171,429 )

 

 

(297,236 )

 

 

(534,028 )

Provision for income tax:

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net income (loss)

 

$ (94,215 )

 

$ (171,429 )

 

$ (297,236 )

 

$ (534,028 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Basic and fully diluted)

 

$ (0.01 )

 

$ (0.01 )

 

$ (0.02 )

 

$ (0.03 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding

 

 

18,460,983

 

 

 

18,360,983

 

 

 

18,435,890

 

 

 

18,233,937

 

 

The accompanying notes are an integral part of the audited financial statements.

 

 
F-3
 
Table of Contents

 

JUBILANT FLAME INTERNATIONAL, LTD

Statements of Changes in Stockholders' Deficit

(Unaudited)

 

 

 

Common

Stock

 

 

Additional

paid in

 

 

Accumulated

 

 

Total

Stockholders’

 

 

 

Shares

 

 

Amount

 

 

capital

 

 

deficit

 

 

 Deficit

 

Balances at February 28, 2018

 

 

18,410,708

 

 

$ 18,411

 

 

$ 2,259,120

 

 

$ (3,115,790 )

 

$ (838,259 )

Shares issued for stock compensation

 

 

75,000

 

 

 

75

 

 

 

157,425

 

 

 

 

 

 

 

157,500

 

Net loss for the period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(297,236 )

 

 

(297,236 )

Balances at November 30, 2018

 

 

18,485,708

 

 

$ 18,486

 

 

$ 2,416,545

 

 

$ (3,413,026 )

 

$ (977,995 )

 

The accompanying notes are an integral part of these financial statements

 

 

F-4

 
Table of Contents

 

JUBILANT FLAME INTERNATIONAL, LTD

Statements of Cash Flows

(Unaudited)

 

 

 

For the nine months ended November 30,

 

 

 

2018

 

 

2017

 

Cash Flows from Operating Activities:

 

 

 

 

 

 

Net loss

 

$ (297,236 )

 

$ (534,028 )

Adjustments to reconcile net (loss) to net cash (used in) operating activities

 

 

 

 

 

 

 

 

Website amortization

 

 

3,473

 

 

 

6,250

 

Debt discount amortization

 

 

-

 

 

 

4,238

 

Change in derivatives liability

 

 

-

 

 

 

4,362

 

Derivatives extinguishment gain

 

 

-

 

 

 

(1,242 )

Stock compensation

 

 

157,500

 

 

 

265,125

 

Changes in Current Assets and Liabilities:

 

 

 

 

 

 

 

 

Account receivable

 

 

(2,370 )

 

 

-

 

Inventory

 

 

(3,880 )

 

 

-

 

Prepaid expense

 

 

(4,500 )

 

 

(2,812 )

Accounts payable

 

 

3,170

 

 

 

(575 )

Due to related party

 

 

28,993

 

 

 

 

 

Accrued officer's compensation

 

 

75,375

 

 

 

125,625

 

Net cash used in operating activities

 

 

(39,475 )

 

 

(133,057 )

Cash Flows from Financing Activities:

 

 

 

 

 

 

 

 

Net proceeds from related party loans

 

 

47,321

 

 

 

137,598

 

Debt payoff

 

 

-

 

 

 

(800 )

Net cash provided by financing activities

 

 

47,321

 

 

 

136,798

 

Net Increase In Cash

 

 

7,846

 

 

 

3,741

 

Cash at Beginning of Period

 

 

8,036

 

 

 

3,653

 

Cash at End of Period

 

$ 15,882

 

 

$ 7,394

 

Schedule of Non-Cash Investing and Financing Activities

 

 

 

 

 

 

 

 

Convertible note reduction associated with note conversion

 

 

-

 

 

 

(6,600 )

Derivative liability reduction associated with note conversion

 

 

-

 

 

 

(12,276 )

Officer debt and stock compensation forgiveness

 

 

-

 

 

 

(410,890 )

 

 

$ -

 

 

$ (429,766 )

Supplemental Disclosure

 

 

 

 

 

 

 

 

Cash paid for interest

 

$ -

 

 

$ 320

 

 

The accompanying notes are an integral part of these financial statements

 

 
F-5
 
Table of Contents

 

JUBILANT FLAME INTERNATIONAL, LTD

NOTES TO FINANCIAL STATEMENTS

FOR THE THREE AND NINE MONTH PERIODS ENDED NOVEMBER 30, 2018 AND 2017

(UNAUDITED)

 

NOTE 1 – ORGANIZATION AND OPERATIONS

 

Jubilant Flame International, Ltd. (the "Company"), was formed on September 29, 2009 under the name Liberty Vision, Inc. On August 18, 2015, the Company changed its name to Jubilant Flame International, Ltd.

 

From the fourth quarter of the fiscal year ended February 28, 2018, the Company started to market and sell cosmetics products imported from Asia -Acropass Series products – in the United States market. The Company purchased the inventory from a related party company in China. The Company contracted with a third party to operate the online shopping platform and marketing campaign in the United States.

 

The Company has the right to develop and market medical products under a license from BioMark. The primary intended products include Bone-Induction Artificial Bone (“BIAB”) and Vacuum Sealing Drainage (“VSD”) but the Company currently does not have any plan to deploy such licenses and is focusing its operation on the Acropass products.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The Company’s financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

 

Interim Financial Information

 

Interim financial statements included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") as promulgated in Item 210 of Regulation S-X. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP") have been condensed or omitted pursuant to such SEC rules and regulations. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of financial position as of November 30, 2018, results of operations, changes in stockholders' equity (deficit) and cash flows for the nine month periods ended November 30, 2018 and 2017, as applicable, have been made. The results for these interim periods are not necessarily indicative of the results for the entire year. The accompanying financial statements should be read in conjunction with the financial statements and the notes thereto included in the Company's Form 10-K.

 

Use of Estimates and Assumptions

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

 

The Company’s significant estimates include income tax provisions and valuation allowances of deferred tax assets; the fair value of financial instruments and the assumption that the company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.

 

 
F-6
 
Table of Contents

 

Recent Accounting Pronouncements

 

Pronouncements Adopted in Fiscal 2018

 

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). This ASU represents a single comprehensive model to recognize revenue to depict the transfer of promised goods or services to a customer at an amount that reflects the consideration it expects to be entitled to in exchange for those goods or services. The Company has adopted this ASU since the interim period ending May 31, 2018, under the modified retrospective approach. The implementation of this ASU will result in no adjustment to retained earnings and current financial statements.

 

Net Loss Per Common Share

 

Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted average number of shares of common stock and potentially outstanding shares of common stock during each period.

 

NOTE 3 – GOING CONCERN

 

The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. As of November 30, 2018, the Company had current assets of $40,658, and current liabilities total $1,018,653 resulting in a working capital deficit of $977,995. The Company currently has small scale trading activities and has an accumulated deficit of $3,413,026 as of November 30, 2018. This raises substantial doubt about the Company's ability to continue as a going concern.

 

The Company may raise additional capital through the sale of its equity securities, through an offering of debt securities, or through borrowings from financial institutions or related parties. By doing so, the Company hopes to generate sufficient capital to execute its business plan in the cosmetics and medical sector on an ongoing basis. Management believes that actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern. There is no guarantee the Company will be successful in achieving these objectives.

 

NOTE 4 – PREPAID EXPENSE

 

The Company is paying an annual fee for its OTC Markets service. The new service period is from December 1, 2018 to November 30, 2019. The service charge is recorded as a prepaid expense and amortized using straight line amortization over the service period. The prepaid expense balance is $12,000 as of November 30, 2018 compared to $7,500 as of February 28, 2018.

 

 
F-7
 
Table of Contents

 

NOTE 5 – RELATED PARTY TRANSACTIONS

 

In support of the Company’s efforts and cash requirements, it must rely on advances from related parties until such time that the Company can support its operations or attains adequate financing through sales of its common stock or traditional debt financing. There is no formal written commitment for continued support by shareholders. The advances are considered temporary in nature and have not been formalized by a promissory note.

 

As of November 30, 2018, the Company had a $438,149 loan outstanding with its CEO, Ms. Yan Li. This compares with the outstanding balance of $390,828 to Ms. Yan Li at February 28, 2018. The loans are non-interest bearing, due upon demand and unsecured.

 

A related party is providing accounting service to the company at an estimated annual service fee of $20,000. From November 2017, the Company started to purchase cosmetic products from a related party controlled by our CEO. As of the nine-month period ended November 30, 2018, the Company incurred a total of $41,835 due to related party for inventory purchase and accrued service fee. This compares with a total of $12,842 due to related party for inventory purchase and accrued service fee at February 28, 2018.

 

NOTE 6 – ACCRUED OFFICER COMPENSATION AND STOCK COMPENSATION

 

On December 15, 2015, the Company entered into employment agreements with its president, Ms. Yan Li, and its secretary and treasurer, Mr. Robert Ireland.

 

On August 30, 2017, Mr. Robert Ireland resigned as Secretary/Treasurer of the company.

 

As of November 30, 2018, a total of $535,500 had been accrued as salary compensation payable compared to $460,125 at February 28, 2018 to the president only.

 

During the three months and nine months ended November 30, 2018, a total of $52,500 and $157,500 stock compensation had been recorded to the president respectively compared to $52,500 and $265,125 for the same periods in the prior year to the president and other directors.

 

NOTE 7 – STOCKHOLDERS EQUITY

 

At the nine month period ended November 30, 2018, a total of 75,000 Shares were issued to the president as stock compensation. Total value of $157,500 has been recorded for the stock compensation.

 

NOTE 8 – SUBSEQUENT EVENTS

 

None.

 

 
F-8
 
Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion should be read in conjunction with the financial statements and the notes to those statements included elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Certain statements contained in the MD&A are forward-looking statements that involve risks and uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business and future financial results. Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed in other sections of this Quarterly Report on Form 10-Q.

 

Our Business

 

Jubilant Flame International, Ltd., (the "Company", "the "Registrant", "we", "us" or "our") was formed on September 29, 2009 under the name Liberty Vision, Inc. The Company provided web development and marketing services for clients. On December 5, 2012, the Company disposed of its subsidiary corporation to a shareholder for a nominal sum, as well as other management operations. On December 16, 2012, the Company changed its name to Jiu Feng Investment Hong Kong, Inc. On January 27, 2013, the Company announced the change of its ticker symbol from "LBYV" to "JFIL." On July 24, 2013, the Company changed its business sector to the medical sector. On August 18, 2015 the Company changed its name to Jubilant Flame International, Ltd.

 

From the fourth quarter of the fiscal year ended February 28, 2018, the Company started to market and sell cosmetics products imported from Asia -Acropass Series products – in the United States market. The Company purchased the inventory from a related party company in China. The Company contracted with a third party to operate the online shopping platform and marketing campaign in the United States.

 

The Company has the right to develop and market medical products under a license from BioMark. The primary intended products include Bone-Induction Artificial Bone (“BIAB”) and Vacuum Sealing Drainage (“VSD”) but the company currently does not have any plan to deploy such licenses and is focusing its operation on the Acropass products.

 

Results of Operations

 

Revenue

 

We recognized $24,099 sales revenue in the three months and $38,190 sales revenue in nine months ended November 30, 2018 respectively. There is no sales revenue in the three months and nine months ended November 30, 2017.

 

 
3
 
Table of Contents

 

Operating Expenses

 

For the three months ended November 30,2018 compared to the three months ended November 30,2017

The major components of our operating expenses for the three months ended November 30, 2018 and 2017 are outlined in the table below:

 

 

 

Three Months

Ended

 

 

Three Months

Ended

 

 

 

Nov 30,

 

 

Nov 30,

 

 

 

2018

 

 

2017

 

 

 

 

 

 

 

 

Officer compensation

 

$ 77,625

 

 

$ 77,625

 

Selling expense

 

$ 10,897

 

 

$ -

 

Professional fee

 

$ 10,367

 

 

$ 88,379

 

Office expense

 

$ 69

 

 

$ 1,154

 

Web Amortization expense

 

$ -

 

 

$ 2,083

 

OTC Filing fees

 

$ 2,500

 

 

$ 2,188

 

Total operating expenses

 

$ 101,458

 

 

$ 171,429

 

 

The $69,971 decrease in our operating costs for the three months ended November 30, 2018 compared to three months ended November 30, 2017, was mainly due to the $78,012 decrease in professional fee.

 

For the nine months ended November 30, 2018 compared to the nine months ended November 30, 2017

 

The major components of our operating expenses for the nine months ended November 30, 2018 and 2017 are outlined in the table below:

 

 

 

Nine Months

Ended

 

 

Nine Months

Ended

 

 

 

Nov 30,

 

 

Nov 30,

 

 

 

2018

 

 

2017

 

Officer compensation

 

$ 232,875

 

 

$ 390,750

 

Transfer agent

 

$ 5,000

 

 

$ 4,867

 

Edgar filing fees

 

$ 2,184

 

 

$ 2,346

 

OTC service fees

 

$ 7,500

 

 

$ 7,188

 

Rent

 

$ -

 

 

$ 6,000

 

Office expense

 

$ 1,418

 

 

$ 3,668

 

Web Amortization expense

 

$ 3,473

 

 

$ 6,250

 

Legal fees

 

$ 2,739

 

 

$ 3,760

 

Accounting fees

 

$ 31,500

 

 

$ 24,025

 

Selling and Marketing expense

 

$ 24,395

 

 

$ 77,497

 

Total operating expenses

 

$ 311,084

 

 

$ 526,351

 

 

The $215,267 decrease in our operating costs for the nine months ended November 30, 2018 compared to nine months ended November 30, 2017, was mainly due to the $157,875 decrease in officer compensation due to former treasurer resignation and $53,102 decrease in selling and marketing expense for new cosmetic product.

 

 
4
 
Table of Contents

 

Other Expenses

 

Other expenses is zero for the three months ended November 30, 2018 and 2017 respectively.

 

Other expenses decreased to zero for the nine months ended November 30, 2018, from $7,678 for the nine months ended November 30, 2017. Other expenses consisted primarily of $4,238 decrease in debt discount amortization expense and $3,120 decrease in change in derivatives liability respectively.The change in other expense is mainly due to convertible note pay off in August 2017.

 

Net Loss

 

For the three months ended November 30, 2018, we recognized a net loss of $94,215 compared to the net loss of $171,429 for the corresponding period in 2017.

 

For the nine months ended November 30, 2018, we recognized a net loss of $297,236 compared to the net loss of $534,028 for the corresponding period in 2017.

 

Liquidity and Capital Resources

 

Working Capital

 

 

 

November 30,

2018

 

 

February 28,

2018

 

Current Assets

 

$ 40,658

 

 

$ 22,063

 

Current Liabilities

 

$ 1,018,653

 

 

$ 863,795

 

Working Capital Deficit

 

$ (977,995 )

 

$ (841,732 )

 

As of November 30, 2018, the Company had $40,658 current assets, primarily comprising of inventory of $9,813, cash of $15,881 and prepaid expenses of $12,000, and current liabilities of $1,018,653, resulting in a working capital deficit of $977,995. The Company had limited profitable trading activities and has an accumulated deficit of $3,413,026 as at November 30, 2018. This raises substantial doubt about the Company's ability to continue as a going concern.

 

The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future.

 

Based on the Company’s current operating plan, the Company does not have sufficient cash and cash equivalents to fund its operations for at least the next twelve months. The Company will need to obtain additional financing to operate our business. The Company may raise additional capital through the sale of its equity securities, through an offering of debt securities, or through borrowings from financial institutions or related parties. By doing so, the Company hopes to generate sufficient capital to execute its business plan in the cosmetic and medical sector on an ongoing basis. Management believes that actions presently being taken to obtain additional funding provide the opportunity for the Company to continue as a going concern. There is no guarantee the Company will be successful in achieving these objectives.

 

 
5
 
Table of Contents

 

Cash Flows from Operating Activities

 

Our net cash used in operating activities decreased by $93,582 in the nine months ended November 30, 2018 compared to the net cash used in operating activities in the nine months ended November 30, 2017, representing a decrease of 70%. The decrease in net cash used in operating activities was primarily the result of a $53,102 decrease in selling and marketing expense.

 

Cash Flows from Investing Activities

 

We did not generate or use any cash from investing activities during the three months ended November 30, 2018 or 2017.

 

Cash Flows from Financing Activities

 

Our cash provided by financing activities decreased from $136,798 for the nine months ended November 30, 2017 to $47,321 for the nine months ended November 30, 2018. In both periods, cash was provided by loans from related parties.

 

Future Financings

 

We anticipate that additional funding will be required in the form of equity financing from the sale of our common stock, through an offering of debt securities, or through borrowings from financial institutions or related parties. However, we cannot provide investors with any assurance that we will be able to raise sufficient funding from the sale of our common stock or through a loan from our directors to meet our obligations over the next twelve months.

 

Recent Accounting Pronouncements

 

Pronouncements Adopted in Fiscal 2018

 

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606). This ASU represents a single comprehensive model to recognize revenue to depict the transfer of promised goods or services to a customer at an amount that reflects the consideration it expects to be entitled to in exchange for those goods or services. The Company adopts this ASU for the interim period ending May 31, 2018, under the modified retrospective approach. The implementation of this ASU will result in no adjustment to retained earnings and current financial statements.

 

Off Balance Sheet Arrangements

 

As of November 30, 2018, we did not have any off-balance-sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we have conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded as of the evaluation date that our disclosure controls and procedures were not effective. We are presently examining changes to our procedures and policies to ensure a more timing reporting.

 

 
6
 
Table of Contents

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

We were not subject to any legal proceedings during the nine months ended November 30, 2018, and currently we are not involved in any pending litigation or legal proceedings.

 

ITEM 1A. RISK FACTORS.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

Not applicable.

 

 
7
 
Table of Contents

 

ITEM 6. EXHIBITS

 

The following documents are filed as a part of this report:

 

EXHIBIT

NUMBER

 

DESCRIPTION

31.1

 

Certification of the President and Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

 

Certification of the Chief Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

 

Certification of the President and Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2

 

Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS **

 

XBRL Instance Document

101.SCH **

 

XBRL Taxonomy Extension Schema Document

101.CAL **

 

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF **

 

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB **

 

XBRL Taxonomy Extension Label Linkbase Document

101.PRE **

 

XBRL Taxonomy Extension Presentation Linkbase Document

________

** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

 
8
 
Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

JUBILANT FLAME INTERNATIONAL LTD

 

 

 

 

 

Date: January 10, 2019

By:

/s/ Yan Li

Yan Li

President, Chief Executive Officer (Principal Executive Officer) and Director

Date: January 10, 2019

By:

/s/ Lei Wang

Lei Wang

Chief Financial Officer and Director

 

 

9

 

Jubilant Flame International (USOTC:JFIL)
Historical Stock Chart

1 Year : From Jun 2018 to Jun 2019

Click Here for more Jubilant Flame International Charts.

Jubilant Flame International (USOTC:JFIL)
Intraday Stock Chart

Today : Tuesday 25 June 2019

Click Here for more Jubilant Flame International Charts.

Latest JFIL Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.